Teglutik Liquid
Product Images NDC 70726-0305

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Teglutik (NDC 70726-0305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Edw Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spanish (Spanishteglutik)

Packaging label for Teglutik 5 mg/mL oral suspension containing riluzole. The label includes dosage form as suspension oral, manufacturer EDW Pharma, and package size of 300 mL with a graduated dosing syringe. The text is mainly in Spanish with instructions and regulatory information.*

FDA Label Image

Label (Tiglitik Label)

Tiglutik riluzole oral suspension 50 mg/10 mL (5 mg/mL) label from EDW Pharma. The label includes dosage instructions, storage information, and cautions. It specifies the oral liquid form in a 300 mL bottle, with branding and regulatory details including NDC 70726-0303-2.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.